Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Amiot

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Crohn'S & Colitis|May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort StudyF Poullenot, A Amiot, M Nachury, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Journal of Crohn'S & Colitis|February 21, 2019
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN StudyC Briot, P Faure, A L Parmentier, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Crohn'S & Colitis|May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort StudyF Poullenot, A Amiot, M Nachury, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 9, 2024
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide studyS Bendaoud, S Nahon, L Beaugerie, et al.
Alimentary Pharmacology & Therapeutics|June 9, 2017
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort studyA Amiot, M Serrero, L Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2017
Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohortS Tadbiri, L Peyrin-Biroulet, M Serrero, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Journal of Crohn'S & Colitis|February 21, 2019
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN StudyC Briot, P Faure, A L Parmentier, et al.
Pageof 3